Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652844 · ClinicalTrials.gov registry record · NA
Use of AAM for Correction of Age Related Volume Deficits in the Face
A NA study, sponsored by Musculoskeletal Transplant Foundation.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03652844: Completed NA study, sponsored by Musculoskeletal Transplant Foundation.
NCT03652844 is a NA study that has completed, run by Musculoskeletal Transplant Foundation. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03652844, a NA study, has completed, sponsored by Musculoskeletal Transplant Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. The research will tell whether AAM is effective in maintaining mid-face fullness and whether the appearance of the skin improves after injection.
Primary Outcome
MMVSA measures facial volume deficit, ranging from 1 (fairly full midface) to 4 (substantial loss of fullness in the midface area). Lower values represent a better outcome.
Interventions
- PROCEDURE AAM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2019-07-12 |
| Phase | NA |
What the finished NCT03652844 record still lists
NCT03652844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which AAM is the first listed.
NCT03652844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03652844 about?
NCT03652844 is a clinical study titled "Use of AAM for Correction of Age Related Volume Deficits in the Face". The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. T...
What is the current status of trial NCT03652844?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-08-27. Estimated completion is 2019-07-12.
What interventions are being tested in trial NCT03652844?
The interventions under investigation include: AAM (PROCEDURE).
Who is sponsoring clinical trial NCT03652844?
This trial is sponsored by Musculoskeletal Transplant Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03652844's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI